Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
Eliseu Labigalini Jr, Lucio Ribeiro Rodrigues, Dartiu Xavier Da Silveira
01 October 1999
This study ensued from clinical observations based on spontaneous accounts by crack abusers undergoing their first psychiatric assessment, where they reported using cannabis in an attempt to ease their own withdrawal symptoms.
Janet E. Joy, Stanley J. Watson, Jun Borras, Sebastian Scholl , John A. Benson, Wendy Wolford
01 January 1999
The medical use of marijuana is surrounded by a cloud of social, political, and religious controversy, which obscures the facts that should be considered in the debate. This book summarizes what we know about marijuana from evidence-based medicine--the harm it may do and the relief it may bring to patients. The book helps the reader understand not only what science has to say about medical marijuana but also the logic behind the scientific conclusions.
Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.
An estimated 1,000 Israelis attended a rally in Tel Aviv’s Rabin Square on Saturday night to support the legalization of marijuana. As the crowd chanted phrases like "The people demand legal marijuana," the speakers at the rally sought to frame pot smoking as part of Israel’s national culture, as a unifying factor among the country’s disparate groups and even as a security issue. Medical marijuana, which is hard for patients to receive permission to access, was central to the rally. (See also: Cabinet approves Health Ministry rules on medical marijuana)
Israel's Health Ministry has expressed opposition to granting general practitioners the right to prescribe medical marijuana. Instead, the ministry will certify 10 doctors during the first half of 2014, allowing them to prescribe medicinal marijuana to the growing number of patients who currently use it. These 10, newly certified doctors will join the 20 doctors currently permitted by the Health Ministry to prescribe the drug.
By a narrow margin, Arizona voters have given their OK to legalized medical marijuana for people with chronic or debilitating diseases. The decision makes Arizona the 15th state to approve a medical marijuana law. California was the first in 1996, and 13 other states and Washington, D.C., have followed suit.
The medical marijuana market in the U.S. generates $1.7 billion a year but a new report suggests that number could multiple as more U.S. states legalize it for treating a variety of illnesses. The study says that of the nearly 25 million Americans who are potentially eligible to use medical marijuana based on their diagnoses, fewer than 800,000 currently do.
The Ontario Superior Court in Canada declared the rules that govern medical marijuana access and the prohibitions laid out in sections 4 and 7 of the Controlled Drugs and Substances Act “constitutionally invalid and of no force and effect,” effectively paving the way for legalization. If the government does not respond within 90 days with a successful delay or re-regulation of marijuana, the drug will be legal to possess and produce in Ontario, where the decision is binding.
Threatened medical-marijuana crackdowns by federal prosecutors in other states have stoked fears about whether state employees, dispensary owners and others could be punished for operating under Arizona's fledgling law. Although the Justice Department said in 2009 that it would not prosecute sick people using medical marijuana, U.S. attorneys in California and Washington state have told officials there that they do intend to enforce federal laws that prohibit manufacture and distribution of the drug.
Several states have started reassessing their medical marijuana laws after stern warnings from the federal government that everyone from licensed growers to regulators could be subjected to prosecution.The ominous-sounding letters from U.S. attorneys in recent weeks have directly injected the federal government back into a debate that has for years been progressing at the state level.
Gov. Jack Markell has signed legislation making Delaware the 16th state to allow the use of medical marijuana. The new law allows people 18 and older with certain serious or debilitating conditions that could be alleviated by marijuana to possess up to six ounces of the drug. Qualifying patients would be referred to state-licensed and regulated “compassion centers,” which would be located in each of Delaware’s three counties. The centers would grow, cultivate and dispense the marijuana.
Several members of California's congressional delegation are taking their concerns about a federal crackdown on the state's medical marijuana dispensaries directly to President Barack Obama. In a bipartisan letter signed by nine members of the U.S. House of Representatives, the lawmakers criticized what they called an "unconscionable" multi-state effort targeting medical marijuana dispensaries. They also called for the reclassification of marijuana as a controlled substance subject to fewer federal restrictions.
When Obama first took office in 2009, he promised a drug policy more focused on public health. However, recent statements from the DEA and raids on medical marijuana providers have proved otherwise. External pressures are escalating as drug cartel-led violence across the border intensifies. Internal pressures are also becoming more widespread, as the public is seeing few changes affecting drug policy. Obama should seriously consider re-evaluating his approach to drug policy for his 2012 campaign.
Like every section that's left of the mostly vetoed medical-marijuana-reform law that passed in April, section 403 is vague, confusing, and inadequate to the task of regulating cannabis. Section 403, however, might be the single most important scrap of law to survive Gov. Chris Gregoire's veto pen. It's from this section, after all, that the City of Seattle, just three days ago, effectively legalized medical-marijuana gardens and dispensaries (city officials prefer the term "access points").
Czech doctors, patients and scientists launched a petition for the legal use of marijuana in treating sclerosis multiplex, the Parkinson disease, cancer and the AIDS in the Czech Republic whose legislation bans such practice. The petitioners say the ban breaches people's free choice of treatment methods and want it to be lifted. They give research results and practice in foreign countries as arguments in support of their demand.
Voters narrowly approved a ballot initiative last November allowing medical marijuana in the state, but the result has been just the opposite of an orderly system of dispensing cannabis to the truly sick. Rather, police raids, surreptitious money transfers and unofficial pot clubs have followed passage of the new law, creating a chaotic situation not far removed from the black-market system that has always existed.
Medical marijuana suppliers complain that the Justice Department is tightening the federal government's approach to enforcement. That's a disingenuous response to the department's latest directive that medical marijuana is not a business – though suppliers sure want it to be. The June 29 memo largely reaffirms one from October 2009 – known as the "Ogden" memo. Both memos advise US attorneys that individual marijuana users with serious illnesses – and their caregivers – are not an enforcement priority, but those in the business of cultivating, selling, or distributing marijuana are.
Colorado's medical-marijuana industry took a battering from all sides, as new laws restricting the businesses took effect and the Obama administration made its most explicit threat yet that dispensary raids are still possible. Perhaps the most pressing challenge to Colorado's medical-marijuana businesses came in a U.S. Department of Justice memo. In this week's memo, Deputy Attorney General James Cole wrote that people "who are in the business of cultivating, selling or distributing marijuana and those who knowingly facilitate such activities" are in violation of federal law, regardless of their state laws.